Select publications authored by our scientists.
- Immunology and Infectious Disease
- 2026
Brostoff T, Pires J, Rose A, Cohen-Davidyan T, Castillo D, Murphy BG, Reagan KL
Treatment of non-effusive feline infectious peritonitis using oral remdesivir or GS-441524: a randomized, double-blind, non-inferiority trial
2025
Wanakumjorn P, Kimura K, Castillo D, McLarty E, Formaker R, Qiao R, Farrell K, Brostoff T, Ramarapu R, Pires J, Cohen-Davidyan T, Cassano J, Murphy B, Reagan K, Kol A
Mesenchymal stem/stromal cell therapy improves immune recovery in a feline model of severe coronavirus infection
2024
Murphy BG, Castillo D, Neely NE, Kol A, Brostoff T, Grant CK, Reagan KL
Serologic, Virologic and Pathologic Features of Cats with Naturally Occurring Feline Infectious Peritonitis Enrolled in Antiviral Clinical Trials
2024
Reagan KL, Brostoff T, Pires J, Rose A, Castillo D, Murphy BG
Open label clinical trial of orally administered molnupiravir as a first-line treatment for naturally occurring effusive feline infectious peritonitis - Oncology
- 2025
Luker ME, York D, Al-Nadaf S, Johnson EG, Withers SS, Cruz SM, Lejeune A, Skorupski KA, Young J, Cohen-Davidyan T, Sparger EE, Culp WT, Murphy WJ, Kent MS, Canter RJ, Rebhun RB
Evaluating the impact of doxorubicin preconditioning on the efficacy of inhaled recombinant human IL-15 immunotherapy in dogs with pulmonary metastasis
2024
Burton JH, Vail DM, Willcox JL, Al-Nadaf S, Adrianowycz S, Biggs D, Hayim R, Magee K, McMahon R, Mok I, Picone AM, Ralston J, Smith BM, Uyehara R, Willis AL, Johnston SA, Thamm DH
Low prevalence of occult cancer diagnosis when screening healthy, higher-risk, middle-aged to older dogs
2024
Burton JH, Johnston SA, Vail DM, Eickhoff JC, Sykes KF, Brown JR, Shen L, Gervassi A, Page RL, Willcox JL, Al-Nadaf S, Willis AL, Biggs D, Ralston J, Mok I, Kurzman ID, Huelsmeyer MK, Hayim R, Smith BM, Thamm DH
Design of a randomized, placebo-controlled study evaluating efficacy and safety of a cancer preventative vaccine in dogs
2022
Al-Nadaf S^, Wittenburg LA, Skorupski KA, Burton JH
Population pharmacokinetics identifies rapid gastrointestinal absorption and plasma clearance of oral chlorambucil administered to cats with indolent lymphoproliferative malignancies